Oleander Extract segmentation by application reveals four principal demand clusters. The cosmetics segment, encompassing anti‑aging creams, serums, and sunscreen formulations, accounts for roughly 40 % of total revenue, driven by the compound’s documented antioxidant and melanin‑inhibiting properties. The pharmaceutical segment, representing 35 % of the market, includes topical anti‑inflammatory ointments, cardiotonic preparations, and investigational oncology agents, where the bioactive cardenolides are leveraged for their cytotoxic and cardiotonic effects. The food & beverages segment, contributing about 15 %, is limited to niche functional‑drink additives and confectionery colorants, constrained by regulatory thresholds on toxic glycosides. The remaining 10 % falls under industrial applications such as biocidal coatings and textile dyeing, where the extract’s broad‑spectrum toxicity is exploited. Collectively, these application categories define the overall Oleander Extract segmentation, with the cosmetic and pharmaceutical clusters providing the bulk of volume and pricing power.